nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—Speech impairment NOS—Fluorouracil—colon cancer	0.0345	0.0379	CcSEcCtD
Mitotane—Gastrointestinal toxicity—Capecitabine—colon cancer	0.032	0.0352	CcSEcCtD
Mitotane—Memory loss—Fluorouracil—colon cancer	0.0256	0.0282	CcSEcCtD
Mitotane—Mental retardation—Capecitabine—colon cancer	0.0241	0.0265	CcSEcCtD
Mitotane—Gastrointestinal toxicity—Methotrexate—colon cancer	0.0238	0.0262	CcSEcCtD
Mitotane—Speech impairment NOS—Methotrexate—colon cancer	0.0179	0.0197	CcSEcCtD
Mitotane—FDX1—renal system—colon cancer	0.0164	0.18	CbGeAlD
Mitotane—Polyneuropathy—Capecitabine—colon cancer	0.0161	0.0177	CcSEcCtD
Mitotane—Mucosal inflammation—Irinotecan—colon cancer	0.0142	0.0156	CcSEcCtD
Mitotane—Balance disorder—Fluorouracil—colon cancer	0.0138	0.0151	CcSEcCtD
Mitotane—Hepatitis cholestatic—Capecitabine—colon cancer	0.013	0.0144	CcSEcCtD
Mitotane—FDX1—bone marrow—colon cancer	0.0124	0.136	CbGeAlD
Mitotane—FDX1—vagina—colon cancer	0.0119	0.13	CbGeAlD
Mitotane—Encephalopathy—Fluorouracil—colon cancer	0.0117	0.0129	CcSEcCtD
Mitotane—Retinal disorder—Methotrexate—colon cancer	0.011	0.0121	CcSEcCtD
Mitotane—FDX1—liver—colon cancer	0.01	0.11	CbGeAlD
Mitotane—Balance disorder—Capecitabine—colon cancer	0.00961	0.0106	CcSEcCtD
Mitotane—Mucosal inflammation—Capecitabine—colon cancer	0.00949	0.0104	CcSEcCtD
Mitotane—Hypertriglyceridaemia—Capecitabine—colon cancer	0.00915	0.0101	CcSEcCtD
Mitotane—Speech disorder—Irinotecan—colon cancer	0.00913	0.01	CcSEcCtD
Mitotane—Speech disorder—Fluorouracil—colon cancer	0.00875	0.00962	CcSEcCtD
Mitotane—Dysarthria—Irinotecan—colon cancer	0.0083	0.00914	CcSEcCtD
Mitotane—Encephalopathy—Capecitabine—colon cancer	0.00819	0.00901	CcSEcCtD
Mitotane—Hypothyroidism—Capecitabine—colon cancer	0.00819	0.00901	CcSEcCtD
Mitotane—Blood triglycerides increased—Capecitabine—colon cancer	0.00802	0.00883	CcSEcCtD
Mitotane—Dysarthria—Fluorouracil—colon cancer	0.00795	0.00875	CcSEcCtD
Mitotane—FDX1—lymph node—colon cancer	0.00768	0.0843	CbGeAlD
Mitotane—Salivary hypersecretion—Irinotecan—colon cancer	0.00763	0.00839	CcSEcCtD
Mitotane—Neoplasm—Irinotecan—colon cancer	0.0071	0.00781	CcSEcCtD
Mitotane—SERPINA6—renal system—colon cancer	0.00708	0.0777	CbGeAlD
Mitotane—Mucosal inflammation—Methotrexate—colon cancer	0.00707	0.00778	CcSEcCtD
Mitotane—Fungal infection—Capecitabine—colon cancer	0.00681	0.00749	CcSEcCtD
Mitotane—Injury—Irinotecan—colon cancer	0.0062	0.00682	CcSEcCtD
Mitotane—Encephalopathy—Methotrexate—colon cancer	0.0061	0.00671	CcSEcCtD
Mitotane—Proteinuria—Capecitabine—colon cancer	0.00598	0.00658	CcSEcCtD
Mitotane—Protein urine present—Capecitabine—colon cancer	0.0059	0.00649	CcSEcCtD
Mitotane—Amnesia—Fluorouracil—colon cancer	0.00581	0.00639	CcSEcCtD
Mitotane—Osteoarthritis—Irinotecan—colon cancer	0.0057	0.00627	CcSEcCtD
Mitotane—Lethargy—Fluorouracil—colon cancer	0.00557	0.00613	CcSEcCtD
Mitotane—Dysarthria—Capecitabine—colon cancer	0.00556	0.00611	CcSEcCtD
Mitotane—Cataract—Capecitabine—colon cancer	0.00552	0.00608	CcSEcCtD
Mitotane—Ataxia—Vincristine—colon cancer	0.0055	0.00606	CcSEcCtD
Mitotane—Osteoarthritis—Fluorouracil—colon cancer	0.00546	0.00601	CcSEcCtD
Mitotane—SERPINA6—bone marrow—colon cancer	0.00535	0.0588	CbGeAlD
Mitotane—Irritability—Fluorouracil—colon cancer	0.00521	0.00573	CcSEcCtD
Mitotane—Orthostatic hypotension—Irinotecan—colon cancer	0.00521	0.00573	CcSEcCtD
Mitotane—Muscular weakness—Vincristine—colon cancer	0.00516	0.00568	CcSEcCtD
Mitotane—Ataxia—Fluorouracil—colon cancer	0.00513	0.00565	CcSEcCtD
Mitotane—Fungal infection—Methotrexate—colon cancer	0.00507	0.00558	CcSEcCtD
Mitotane—Muscular weakness—Fluorouracil—colon cancer	0.00482	0.0053	CcSEcCtD
Mitotane—Neoplasm—Capecitabine—colon cancer	0.00475	0.00523	CcSEcCtD
Mitotane—Neutropenia—Vincristine—colon cancer	0.00473	0.00521	CcSEcCtD
Mitotane—Neutropenia—Irinotecan—colon cancer	0.00461	0.00507	CcSEcCtD
Mitotane—Mental disability—Capecitabine—colon cancer	0.00456	0.00502	CcSEcCtD
Mitotane—Speech disorder—Methotrexate—colon cancer	0.00455	0.00501	CcSEcCtD
Mitotane—SHBG—bone marrow—colon cancer	0.00451	0.0495	CbGeAlD
Mitotane—Proteinuria—Methotrexate—colon cancer	0.00445	0.0049	CcSEcCtD
Mitotane—Protein urine present—Methotrexate—colon cancer	0.00439	0.00483	CcSEcCtD
Mitotane—SERPINA6—liver—colon cancer	0.00433	0.0475	CbGeAlD
Mitotane—SHBG—vagina—colon cancer	0.00432	0.0474	CbGeAlD
Mitotane—Infestation NOS—Fluorouracil—colon cancer	0.00421	0.00463	CcSEcCtD
Mitotane—Infestation—Fluorouracil—colon cancer	0.00421	0.00463	CcSEcCtD
Mitotane—Hepatic enzyme increased—Methotrexate—colon cancer	0.00414	0.00455	CcSEcCtD
Mitotane—Dysarthria—Methotrexate—colon cancer	0.00414	0.00455	CcSEcCtD
Mitotane—Amnesia—Capecitabine—colon cancer	0.00406	0.00447	CcSEcCtD
Mitotane—Urinary tract disorder—Vincristine—colon cancer	0.004	0.0044	CcSEcCtD
Mitotane—Connective tissue disorder—Vincristine—colon cancer	0.00398	0.00438	CcSEcCtD
Mitotane—Urethral disorder—Vincristine—colon cancer	0.00397	0.00437	CcSEcCtD
Mitotane—Lethargy—Capecitabine—colon cancer	0.00389	0.00428	CcSEcCtD
Mitotane—Connective tissue disorder—Irinotecan—colon cancer	0.00388	0.00426	CcSEcCtD
Mitotane—Diplopia—Capecitabine—colon cancer	0.00382	0.0042	CcSEcCtD
Mitotane—Osteoarthritis—Capecitabine—colon cancer	0.00382	0.0042	CcSEcCtD
Mitotane—Visual impairment—Irinotecan—colon cancer	0.0038	0.00418	CcSEcCtD
Mitotane—Angiopathy—Vincristine—colon cancer	0.00367	0.00404	CcSEcCtD
Mitotane—Flushing—Irinotecan—colon cancer	0.00366	0.00403	CcSEcCtD
Mitotane—SHBG—liver—colon cancer	0.00365	0.04	CbGeAlD
Mitotane—Irritability—Capecitabine—colon cancer	0.00364	0.00401	CcSEcCtD
Mitotane—Ataxia—Capecitabine—colon cancer	0.00359	0.00395	CcSEcCtD
Mitotane—Angiopathy—Irinotecan—colon cancer	0.00358	0.00394	CcSEcCtD
Mitotane—Mental disorder—Vincristine—colon cancer	0.00355	0.0039	CcSEcCtD
Mitotane—Neoplasm—Methotrexate—colon cancer	0.00354	0.00389	CcSEcCtD
Mitotane—Gynaecomastia—Methotrexate—colon cancer	0.0035	0.00385	CcSEcCtD
Mitotane—CYP11A1—lymph node—colon cancer	0.00349	0.0383	CbGeAlD
Mitotane—Orthostatic hypotension—Capecitabine—colon cancer	0.00348	0.00383	CcSEcCtD
Mitotane—Breast disorder—Capecitabine—colon cancer	0.00345	0.00379	CcSEcCtD
Mitotane—Muscular weakness—Capecitabine—colon cancer	0.00337	0.0037	CcSEcCtD
Mitotane—Anaemia—Vincristine—colon cancer	0.00326	0.00358	CcSEcCtD
Mitotane—Anaemia—Irinotecan—colon cancer	0.00317	0.00349	CcSEcCtD
Mitotane—Vertigo—Vincristine—colon cancer	0.00317	0.00348	CcSEcCtD
Mitotane—Vision blurred—Fluorouracil—colon cancer	0.0031	0.00341	CcSEcCtD
Mitotane—Vertigo—Irinotecan—colon cancer	0.00308	0.00339	CcSEcCtD
Mitotane—Neutropenia—Capecitabine—colon cancer	0.00308	0.00339	CcSEcCtD
Mitotane—Hypertension—Vincristine—colon cancer	0.00304	0.00335	CcSEcCtD
Mitotane—Anaemia—Fluorouracil—colon cancer	0.00304	0.00334	CcSEcCtD
Mitotane—Hypertension—Irinotecan—colon cancer	0.00296	0.00326	CcSEcCtD
Mitotane—Infestation NOS—Capecitabine—colon cancer	0.00294	0.00323	CcSEcCtD
Mitotane—Infestation—Capecitabine—colon cancer	0.00294	0.00323	CcSEcCtD
Mitotane—Lethargy—Methotrexate—colon cancer	0.0029	0.00319	CcSEcCtD
Mitotane—Infection—Vincristine—colon cancer	0.00286	0.00314	CcSEcCtD
Mitotane—Osteoarthritis—Methotrexate—colon cancer	0.00284	0.00312	CcSEcCtD
Mitotane—Confusional state—Irinotecan—colon cancer	0.00283	0.00311	CcSEcCtD
Mitotane—Nervous system disorder—Vincristine—colon cancer	0.00282	0.0031	CcSEcCtD
Mitotane—Thrombocytopenia—Vincristine—colon cancer	0.00282	0.0031	CcSEcCtD
Mitotane—Haematuria—Capecitabine—colon cancer	0.0028	0.00308	CcSEcCtD
Mitotane—Infection—Irinotecan—colon cancer	0.00278	0.00306	CcSEcCtD
Mitotane—Hepatobiliary disease—Capecitabine—colon cancer	0.00278	0.00306	CcSEcCtD
Mitotane—Shock—Irinotecan—colon cancer	0.00276	0.00303	CcSEcCtD
Mitotane—Nervous system disorder—Irinotecan—colon cancer	0.00275	0.00302	CcSEcCtD
Mitotane—Thrombocytopenia—Irinotecan—colon cancer	0.00274	0.00302	CcSEcCtD
Mitotane—Anorexia—Vincristine—colon cancer	0.00274	0.00302	CcSEcCtD
Mitotane—Irritability—Methotrexate—colon cancer	0.00271	0.00298	CcSEcCtD
Mitotane—Confusional state—Fluorouracil—colon cancer	0.00271	0.00298	CcSEcCtD
Mitotane—Hypotension—Vincristine—colon cancer	0.00269	0.00296	CcSEcCtD
Mitotane—Anorexia—Irinotecan—colon cancer	0.00267	0.00294	CcSEcCtD
Mitotane—Ataxia—Methotrexate—colon cancer	0.00267	0.00294	CcSEcCtD
Mitotane—Infection—Fluorouracil—colon cancer	0.00267	0.00293	CcSEcCtD
Mitotane—Hepatitis—Capecitabine—colon cancer	0.00264	0.0029	CcSEcCtD
Mitotane—Nervous system disorder—Fluorouracil—colon cancer	0.00263	0.0029	CcSEcCtD
Mitotane—Thrombocytopenia—Fluorouracil—colon cancer	0.00263	0.00289	CcSEcCtD
Mitotane—Hypotension—Irinotecan—colon cancer	0.00262	0.00288	CcSEcCtD
Mitotane—Urinary tract disorder—Capecitabine—colon cancer	0.00261	0.00287	CcSEcCtD
Mitotane—Connective tissue disorder—Capecitabine—colon cancer	0.00259	0.00285	CcSEcCtD
Mitotane—Urethral disorder—Capecitabine—colon cancer	0.00259	0.00285	CcSEcCtD
Mitotane—Paraesthesia—Vincristine—colon cancer	0.00258	0.00284	CcSEcCtD
Mitotane—Breast disorder—Methotrexate—colon cancer	0.00257	0.00282	CcSEcCtD
Mitotane—Anorexia—Fluorouracil—colon cancer	0.00256	0.00281	CcSEcCtD
Mitotane—Visual impairment—Capecitabine—colon cancer	0.00254	0.0028	CcSEcCtD
Mitotane—Paraesthesia—Irinotecan—colon cancer	0.00252	0.00277	CcSEcCtD
Mitotane—Hypotension—Fluorouracil—colon cancer	0.00251	0.00276	CcSEcCtD
Mitotane—Decreased appetite—Vincristine—colon cancer	0.0025	0.00275	CcSEcCtD
Mitotane—Somnolence—Irinotecan—colon cancer	0.00249	0.00274	CcSEcCtD
Mitotane—Gastrointestinal disorder—Vincristine—colon cancer	0.00248	0.00273	CcSEcCtD
Mitotane—Eye disorder—Capecitabine—colon cancer	0.00247	0.00271	CcSEcCtD
Mitotane—Dyspepsia—Irinotecan—colon cancer	0.00247	0.00271	CcSEcCtD
Mitotane—Pain—Vincristine—colon cancer	0.00246	0.00271	CcSEcCtD
Mitotane—Flushing—Capecitabine—colon cancer	0.00245	0.0027	CcSEcCtD
Mitotane—Decreased appetite—Irinotecan—colon cancer	0.00244	0.00268	CcSEcCtD
Mitotane—Gastrointestinal disorder—Irinotecan—colon cancer	0.00242	0.00266	CcSEcCtD
Mitotane—Paraesthesia—Fluorouracil—colon cancer	0.00241	0.00265	CcSEcCtD
Mitotane—Pain—Irinotecan—colon cancer	0.0024	0.00264	CcSEcCtD
Mitotane—Angiopathy—Capecitabine—colon cancer	0.00239	0.00263	CcSEcCtD
Mitotane—Somnolence—Fluorouracil—colon cancer	0.00239	0.00262	CcSEcCtD
Mitotane—Dyspepsia—Fluorouracil—colon cancer	0.00236	0.0026	CcSEcCtD
Mitotane—Decreased appetite—Fluorouracil—colon cancer	0.00233	0.00257	CcSEcCtD
Mitotane—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00232	0.00255	CcSEcCtD
Mitotane—Mental disorder—Capecitabine—colon cancer	0.00231	0.00254	CcSEcCtD
Mitotane—Feeling abnormal—Irinotecan—colon cancer	0.00231	0.00254	CcSEcCtD
Mitotane—Malnutrition—Capecitabine—colon cancer	0.0023	0.00253	CcSEcCtD
Mitotane—Neutropenia—Methotrexate—colon cancer	0.0023	0.00253	CcSEcCtD
Mitotane—Pain—Fluorouracil—colon cancer	0.00229	0.00252	CcSEcCtD
Mitotane—Body temperature increased—Vincristine—colon cancer	0.00227	0.0025	CcSEcCtD
Mitotane—Dysgeusia—Capecitabine—colon cancer	0.00225	0.00248	CcSEcCtD
Mitotane—Body temperature increased—Irinotecan—colon cancer	0.00221	0.00244	CcSEcCtD
Mitotane—Feeling abnormal—Fluorouracil—colon cancer	0.00221	0.00243	CcSEcCtD
Mitotane—Drowsiness—Methotrexate—colon cancer	0.00219	0.00241	CcSEcCtD
Mitotane—Infestation NOS—Methotrexate—colon cancer	0.00219	0.00241	CcSEcCtD
Mitotane—Infestation—Methotrexate—colon cancer	0.00219	0.00241	CcSEcCtD
Mitotane—Vision blurred—Capecitabine—colon cancer	0.00217	0.00238	CcSEcCtD
Mitotane—Tremor—Capecitabine—colon cancer	0.00215	0.00237	CcSEcCtD
Mitotane—Anaemia—Capecitabine—colon cancer	0.00212	0.00234	CcSEcCtD
Mitotane—Body temperature increased—Fluorouracil—colon cancer	0.00212	0.00233	CcSEcCtD
Mitotane—Hypersensitivity—Vincristine—colon cancer	0.00212	0.00233	CcSEcCtD
Mitotane—Haematuria—Methotrexate—colon cancer	0.00209	0.0023	CcSEcCtD
Mitotane—Hepatobiliary disease—Methotrexate—colon cancer	0.00207	0.00228	CcSEcCtD
Mitotane—Vertigo—Capecitabine—colon cancer	0.00206	0.00227	CcSEcCtD
Mitotane—Hypersensitivity—Irinotecan—colon cancer	0.00206	0.00227	CcSEcCtD
Mitotane—Asthenia—Vincristine—colon cancer	0.00206	0.00227	CcSEcCtD
Mitotane—Asthenia—Irinotecan—colon cancer	0.00201	0.00221	CcSEcCtD
Mitotane—Hypertension—Capecitabine—colon cancer	0.00198	0.00218	CcSEcCtD
Mitotane—Hypersensitivity—Fluorouracil—colon cancer	0.00198	0.00218	CcSEcCtD
Mitotane—Diarrhoea—Vincristine—colon cancer	0.00197	0.00217	CcSEcCtD
Mitotane—Hepatitis—Methotrexate—colon cancer	0.00196	0.00216	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00194	0.00214	CcSEcCtD
Mitotane—Urinary tract disorder—Methotrexate—colon cancer	0.00194	0.00213	CcSEcCtD
Mitotane—Urethral disorder—Methotrexate—colon cancer	0.00193	0.00212	CcSEcCtD
Mitotane—Diarrhoea—Irinotecan—colon cancer	0.00192	0.00211	CcSEcCtD
Mitotane—Dizziness—Vincristine—colon cancer	0.0019	0.00209	CcSEcCtD
Mitotane—Visual impairment—Methotrexate—colon cancer	0.00189	0.00208	CcSEcCtD
Mitotane—Confusional state—Capecitabine—colon cancer	0.00189	0.00208	CcSEcCtD
Mitotane—Infection—Capecitabine—colon cancer	0.00186	0.00205	CcSEcCtD
Mitotane—Dizziness—Irinotecan—colon cancer	0.00185	0.00204	CcSEcCtD
Mitotane—Shock—Capecitabine—colon cancer	0.00184	0.00203	CcSEcCtD
Mitotane—Nervous system disorder—Capecitabine—colon cancer	0.00184	0.00202	CcSEcCtD
Mitotane—Eye disorder—Methotrexate—colon cancer	0.00184	0.00202	CcSEcCtD
Mitotane—Diarrhoea—Fluorouracil—colon cancer	0.00184	0.00202	CcSEcCtD
Mitotane—Thrombocytopenia—Capecitabine—colon cancer	0.00184	0.00202	CcSEcCtD
Mitotane—Vomiting—Vincristine—colon cancer	0.00183	0.00201	CcSEcCtD
Mitotane—Skin disorder—Capecitabine—colon cancer	0.00182	0.002	CcSEcCtD
Mitotane—Rash—Vincristine—colon cancer	0.00181	0.002	CcSEcCtD
Mitotane—Dermatitis—Vincristine—colon cancer	0.00181	0.00199	CcSEcCtD
Mitotane—Headache—Vincristine—colon cancer	0.0018	0.00198	CcSEcCtD
Mitotane—Anorexia—Capecitabine—colon cancer	0.00179	0.00197	CcSEcCtD
Mitotane—Angiopathy—Methotrexate—colon cancer	0.00178	0.00196	CcSEcCtD
Mitotane—Vomiting—Irinotecan—colon cancer	0.00178	0.00196	CcSEcCtD
Mitotane—Dizziness—Fluorouracil—colon cancer	0.00177	0.00195	CcSEcCtD
Mitotane—Rash—Irinotecan—colon cancer	0.00177	0.00194	CcSEcCtD
Mitotane—Dermatitis—Irinotecan—colon cancer	0.00177	0.00194	CcSEcCtD
Mitotane—Headache—Irinotecan—colon cancer	0.00176	0.00193	CcSEcCtD
Mitotane—Hypotension—Capecitabine—colon cancer	0.00175	0.00193	CcSEcCtD
Mitotane—Mental disorder—Methotrexate—colon cancer	0.00172	0.00189	CcSEcCtD
Mitotane—Malnutrition—Methotrexate—colon cancer	0.00171	0.00188	CcSEcCtD
Mitotane—Nausea—Vincristine—colon cancer	0.00171	0.00188	CcSEcCtD
Mitotane—Vomiting—Fluorouracil—colon cancer	0.00171	0.00188	CcSEcCtD
Mitotane—Rash—Fluorouracil—colon cancer	0.00169	0.00186	CcSEcCtD
Mitotane—Dermatitis—Fluorouracil—colon cancer	0.00169	0.00186	CcSEcCtD
Mitotane—Paraesthesia—Capecitabine—colon cancer	0.00168	0.00185	CcSEcCtD
Mitotane—Headache—Fluorouracil—colon cancer	0.00168	0.00185	CcSEcCtD
Mitotane—Dysgeusia—Methotrexate—colon cancer	0.00168	0.00184	CcSEcCtD
Mitotane—Nausea—Irinotecan—colon cancer	0.00166	0.00183	CcSEcCtD
Mitotane—Dyspepsia—Capecitabine—colon cancer	0.00165	0.00182	CcSEcCtD
Mitotane—Decreased appetite—Capecitabine—colon cancer	0.00163	0.00179	CcSEcCtD
Mitotane—Gastrointestinal disorder—Capecitabine—colon cancer	0.00162	0.00178	CcSEcCtD
Mitotane—Vision blurred—Methotrexate—colon cancer	0.00161	0.00177	CcSEcCtD
Mitotane—Pain—Capecitabine—colon cancer	0.0016	0.00176	CcSEcCtD
Mitotane—Nausea—Fluorouracil—colon cancer	0.00159	0.00175	CcSEcCtD
Mitotane—Anaemia—Methotrexate—colon cancer	0.00158	0.00174	CcSEcCtD
Mitotane—Feeling abnormal—Capecitabine—colon cancer	0.00155	0.0017	CcSEcCtD
Mitotane—Vertigo—Methotrexate—colon cancer	0.00154	0.00169	CcSEcCtD
Mitotane—Body temperature increased—Capecitabine—colon cancer	0.00148	0.00163	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00145	0.00159	CcSEcCtD
Mitotane—Confusional state—Methotrexate—colon cancer	0.00141	0.00155	CcSEcCtD
Mitotane—Infection—Methotrexate—colon cancer	0.00139	0.00153	CcSEcCtD
Mitotane—Hypersensitivity—Capecitabine—colon cancer	0.00138	0.00152	CcSEcCtD
Mitotane—Nervous system disorder—Methotrexate—colon cancer	0.00137	0.00151	CcSEcCtD
Mitotane—Thrombocytopenia—Methotrexate—colon cancer	0.00137	0.0015	CcSEcCtD
Mitotane—Skin disorder—Methotrexate—colon cancer	0.00136	0.00149	CcSEcCtD
Mitotane—Asthenia—Capecitabine—colon cancer	0.00135	0.00148	CcSEcCtD
Mitotane—Anorexia—Methotrexate—colon cancer	0.00133	0.00146	CcSEcCtD
Mitotane—Hypotension—Methotrexate—colon cancer	0.0013	0.00144	CcSEcCtD
Mitotane—Diarrhoea—Capecitabine—colon cancer	0.00128	0.00141	CcSEcCtD
Mitotane—Paraesthesia—Methotrexate—colon cancer	0.00125	0.00138	CcSEcCtD
Mitotane—Somnolence—Methotrexate—colon cancer	0.00124	0.00137	CcSEcCtD
Mitotane—Dizziness—Capecitabine—colon cancer	0.00124	0.00136	CcSEcCtD
Mitotane—Dyspepsia—Methotrexate—colon cancer	0.00123	0.00135	CcSEcCtD
Mitotane—Decreased appetite—Methotrexate—colon cancer	0.00121	0.00134	CcSEcCtD
Mitotane—Gastrointestinal disorder—Methotrexate—colon cancer	0.00121	0.00133	CcSEcCtD
Mitotane—Pain—Methotrexate—colon cancer	0.00119	0.00131	CcSEcCtD
Mitotane—Vomiting—Capecitabine—colon cancer	0.00119	0.00131	CcSEcCtD
Mitotane—Rash—Capecitabine—colon cancer	0.00118	0.0013	CcSEcCtD
Mitotane—Dermatitis—Capecitabine—colon cancer	0.00118	0.0013	CcSEcCtD
Mitotane—Headache—Capecitabine—colon cancer	0.00117	0.00129	CcSEcCtD
Mitotane—Feeling abnormal—Methotrexate—colon cancer	0.00115	0.00127	CcSEcCtD
Mitotane—Nausea—Capecitabine—colon cancer	0.00111	0.00123	CcSEcCtD
Mitotane—Body temperature increased—Methotrexate—colon cancer	0.0011	0.00121	CcSEcCtD
Mitotane—Hypersensitivity—Methotrexate—colon cancer	0.00103	0.00113	CcSEcCtD
Mitotane—Asthenia—Methotrexate—colon cancer	0.001	0.0011	CcSEcCtD
Mitotane—Diarrhoea—Methotrexate—colon cancer	0.000955	0.00105	CcSEcCtD
Mitotane—Dizziness—Methotrexate—colon cancer	0.000923	0.00102	CcSEcCtD
Mitotane—Vomiting—Methotrexate—colon cancer	0.000888	0.000977	CcSEcCtD
Mitotane—Rash—Methotrexate—colon cancer	0.00088	0.000968	CcSEcCtD
Mitotane—Dermatitis—Methotrexate—colon cancer	0.000879	0.000968	CcSEcCtD
Mitotane—Headache—Methotrexate—colon cancer	0.000875	0.000962	CcSEcCtD
Mitotane—Nausea—Methotrexate—colon cancer	0.000829	0.000912	CcSEcCtD
